AU4947700A - An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof - Google Patents

An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof

Info

Publication number
AU4947700A
AU4947700A AU49477/00A AU4947700A AU4947700A AU 4947700 A AU4947700 A AU 4947700A AU 49477/00 A AU49477/00 A AU 49477/00A AU 4947700 A AU4947700 A AU 4947700A AU 4947700 A AU4947700 A AU 4947700A
Authority
AU
Australia
Prior art keywords
hepatitis
preparation
treatment
enriched fraction
fraction prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49477/00A
Inventor
Pala Bushanam Janardhan
Alaganandam Kumaran
Manakkal Sivaraman Premila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOUTHERN PETROCHEMICAL INDUSTRIES Corp Ltd
Original Assignee
SOUTHERN PETROCHEMICAL IND COR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOUTHERN PETROCHEMICAL IND COR filed Critical SOUTHERN PETROCHEMICAL IND COR
Publication of AU4947700A publication Critical patent/AU4947700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU49477/00A 1999-03-24 2000-03-23 An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof Abandoned AU4947700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN339MA1999 1999-03-24
IN339/MAS/99 1999-03-24
PCT/IN2000/000029 WO2000056347A1 (en) 1999-03-24 2000-03-23 An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof

Publications (1)

Publication Number Publication Date
AU4947700A true AU4947700A (en) 2000-10-09

Family

ID=11094863

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49477/00A Abandoned AU4947700A (en) 1999-03-24 2000-03-23 An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof

Country Status (2)

Country Link
AU (1) AU4947700A (en)
WO (1) WO2000056347A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2334754A1 (en) * 1999-04-12 2000-10-19 University Of Madras A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation
ATE275413T1 (en) * 2000-10-06 2004-09-15 Phytrix Ag METHOD FOR PRODUCING PHYLLANTHUS EXTRACTS
DE10120627A1 (en) * 2001-04-26 2002-10-31 Cmi Ag Use of phyllanthus components for the treatment or prophylaxis of infections caused by hepatitis B viruses
DE10155517A1 (en) * 2001-11-13 2003-05-28 Metanomics Gmbh & Co Kgaa Extracting components from organic material, useful e.g. in large-scale metabolic profiling, comprises using a single-phase mixture containing water and methanol
CN110964030A (en) * 2019-12-19 2020-04-07 浙江工业大学 Ball-milling auxiliary extraction method for separating and preparing ellagic acid from phyllanthus urinaria

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673575A (en) * 1985-04-26 1987-06-16 Fox Chase Cancer Center Composition, pharmaceutical preparation and method for treating viral hepatitus

Also Published As

Publication number Publication date
WO2000056347A1 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
IL119833A0 (en) Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
ZA99368B (en) Preparation of sterol and stanol esters.
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU4954397A (en) Multifunctional microstructures and preparation thereof
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2212299A (en) Compositions and methods for the treatment of tumor
AU4479897A (en) Compositions including r-nsaids and therapeutic and prophylactic methods employing said compositions
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU8370298A (en) Process for preparation of soft magnetic composites and the composites prepared
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU715620C (en) Therapeutic methods and uses
IL125598A0 (en) Mixtures which may be isolated from eugenia jambolana lamarck their preparation and use of these mixtures and some of their constituents as medications
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU4947700A (en) An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof
AU4511201A (en) Compositions and methods for the induction and treatment of retinal detachments
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
GB2331460B (en) Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
AU5446798A (en) Compositions and methods for the treatment of gastrointestinal disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase